Preserving Clinical Trial Integrity During the Coronavirus Pandemic.

McDermott, Mary M; Newman, Anne B

McDermott, Mary M; Newman, Anne B.

McDermott MM; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Newman AB; Deputy Editor.

JAMA ; 323(21): 2135-2136, 2020 Jun 02.

Article in English | MEDLINE | ID: covidwho-15732

Subject(s)

Betacoronavirus; Coronavirus Infections/epidemiology; Medical Staff; Patient Safety; Pneumonia, Viral/epidemiology; Randomized Controlled Trials as Topic/standards; Appointments and Schedules; COVID-19; Cell Phone; Coronavirus Infections/prevention & control; Electronic Mail; Guidelines as Topic; Humans; Intention to Treat Analysis; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Quality Control; Randomized Controlled Trials as Topic/statistics & numerical data; Risk Assessment; SARS-CoV-2; Surveys and Questionnaires; Transportation of Patients/methods; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Randomized Controlled Trials as Topic / Coronavirus Infections / Patient Safety / Betacoronavirus / Medical Staff Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: JAMA Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google